Warhound, a Dallas, Texas-based defense technology startup developing genetically enhanced working dogs, emerged from stealth on October 22, 2026, with $200 million in seed funding led by Sequoia Capital.
The round included participation from In-Q-Tel, ARK Invest, Franklin Templeton, 8VC, USIT, Bob Nelsen, Breyer Capital, CAZ Investments, Neogenesis, Builders VC, and Lux Capital, among other investors. The financing valued Warhound at $1.2 billion.
Warhound was conceived by Ben Lamm, co-founder and CEO of Colossal Biosciences, and Palmer Luckey, founder of Anduril Industries. The company is led by CEO David Spirk, a former US Marine and former chief data officer at the US Department of Defense.
Warhound is developing a domestic supply of working dogs for the US military, law enforcement agencies, and emergency response teams. Its approach combines genetic engineering, cloning, specialized training, and protective technologies to improve canine health, performance, and operational safety.
The company plans to use biotechnology licensed from Colossal Biosciences to preserve genetic material from high-performing working dogs and reproduce selected animals through cloning. Its genetic research will also focus on identifying and addressing inherited health conditions that can affect working dogs during training and service.
Anduril Industries will contribute protective equipment, software, and situational awareness technology. These systems are intended to improve communication and coordination between dogs, handlers, and other defense systems during operations.
Warhound aims to reduce US dependence on imported military working dogs, particularly those sourced from Europe. The company said its approach would address supply constraints while improving breeding, training, and animal welfare practices.
The startup is also working with the American Humane Society on animal welfare oversight, training certification, and programs supporting retired military working dogs, including reunification with former handlers and adoption arrangements.
Warhound’s first cloned dogs are expected to be born in 2027, with initial service deployment targeted within approximately two years of the announcement. The company had not secured signed customers at the time of its launch.
